Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stockwatch: BioMarin's Biggest Liabilities

This article was originally published in Scrip

Executive Summary

In an amalgamation of human resources jargon and accounting-speak, many companies describe their employees as their 'greatest asset'. In a similar but inverse metaphor, when many investors think of risk, they only think of the potential to lose money, rather than the chances of making excess positive returns. Despite losing only 13.6% of its value in the past two weeks (over which time admittedly the NASDAQ Biotech Index gained 4.5%), BioMarin Pharmaceutical, Inc. has demonstrated that a company's employees can also be its biggest liability.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC063835

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel